This information is shared in a variety of locations and formats, including individually published papers, websites, and conference presentations. The Playbook is being created to enable access to these learnings in a single location. The Regulatory Chapter is now available… Read more

SPEAC’s Special Populations team, in collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, has launched an LSR and meta-analysis tool focused on the safety, effectiveness, and immunogenicity of Chikungunya vaccines Read more

The objective of the RPP is to leverage investments for advanced-stage clinical development of CEPI's portfolio vaccines and support countries in key regions to generate emergency evidence in future outbreaks Read more

The two countries will enrol 1,000 people (of all ages) each, with coordination by CEPI’s Enable team, headed by Dr H. Mandi, and local and international partners. Three sites in Nigeria recruited 1,000 participants each at the end of 2024; ... Read more

A team of scientists from the UK, Kenya, and Tanzania will explore the extent to which chikungunya affects countries in East Africa. The results will be crucial in guiding the design and implementation of future vaccine trials. Read more

The resource page features a protocol template (for cohort event monitoring for active safety surveillance after vaccination with mpox vaccines), a list of adverse events of special interest, CEM questionnaires, an adult informed consent form, key elements for data collection... Read more